Skip to Content

Profound Medical Corp.

Company NameProfound Medical Corp.
Stock SymbolPROF

On March 7, 2025, Profound disclosed that it had “identified an error which overstated revenue by $472,000 in the first quarter of 2024.” The Company stated correction of this error “reduced revenue previously presented . . . in the first quarter, and in the year-to-date figures in the second and third quarters of 2024.” The Company advised that the affected financial statements “should no longer be relied upon as a result of the foregoing error.”

On this news, Profound’s stock price fell $0.43, or 5.9%, to close at $6.86 per share on March 7, 2025, thereby injuring investors.

Submit Your Information

If you suffered a loss on your Profound Medical Corp. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Shares Purchased

Number of SharesBuy DatePrice Per ShareAdd

Shares Sold

Number of SharesSell DatePrice Per ShareAdd